35 min listen
Possible treatment for COVID-19 related respiratory failure
Possible treatment for COVID-19 related respiratory failure
ratings:
Length:
22 minutes
Released:
Dec 2, 2020
Format:
Podcast episode
Description
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Jonathan Javitt, CEO of NeuroRx. Dr Javitt discusses how NeuroRx is working in collaboration with Relief Therapeutics on Aviptadil, a synthetic version of vasoactive intestinal peptide, and a potential treatment of COVID-19 related respiratory failure. Dr. Javitt shares the promising results of an open label study of the drug, and the company’s plans if trials are successful. Hosted on Acast. See acast.com/privacy for more information.
Released:
Dec 2, 2020
Format:
Podcast episode
Titles in the series (48)
Pivoting a product launch during the pandemic by Conversations in Healthcare